Femasys Inc.FEMYNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P36
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 2025-2.29%
Q2 2025-52.35%
Q1 202537.00%
Q4 2024-5.93%
Q3 202416.57%
Q2 202411.59%
Q1 2024-14.51%
Q4 2023-0.08%
Q3 202335.73%
Q2 2023-0.67%
Q1 202320.91%
Q4 2022-22.85%
Q3 202211.90%
Q2 20223.65%
Q1 202234.85%
Q4 2021-7.60%
Q3 202127.46%
Q2 2021-10.07%
Q1 202111.10%
Q4 2020-10.05%
Q3 202012.03%
Q2 2020-34.20%
Q1 20200.00%